News
Music therapy helps AYAs undergoing HSCT
- Author:
- HT Staff
Credit: Chad McNeeley A music therapy intervention can help adolescents and young adults (AYAs) cope with cancer and its treatment, according to...
News
Ibrutinib trial stopped early
- Author:
- HT Staff
Credit: Steven Harbour The phase 3 RESONATE study has been stopped early due to positive results in patients receiving ibrutinib. In this trial...
News
Mutation could be target for MDS/AML treatment
- Author:
- HT Staff
Scientists have found evidence to suggest that a genetic alteration in osteoblasts can induce acute myeloid leukemia (AML). And this provides a...
News
High-volume centers better for severe sepsis patients
- Author:
- HT Staff
Credit: CDC A new study suggests that “practice makes perfect” when it comes to caring for patients with severe sepsis. Researchers found that...
News
Sickle cell trait affects need for ESAs
- Author:
- HT Staff
Researchers may have discovered why African Americans on dialysis sometimes require higher doses of erythropoietin-stimulating agents (ESAs) than...
News
Group simulates blood vessel growth
- Author:
- HT Staff
Louis Heiser & Robert Ackland Bioengineers say they’ve found a way to accurately predict blood vessel growth, and this finding has...
News
Study explains why FDA rejects new drug applications
- Author:
- HT Staff
Credit: Esther Dyson New research suggests that drugs are often rejected by the US Food and Drug Administration (FDA), not because they are...
News
Adding idelalisib improves CLL treatment
- Author:
- HT Staff
The PI3K delta inhibitor idelalisib could turn chronic lymphocytic leukemia (CLL) into a highly treatable disease, according to the lead...
News
FDA doesn’t hold drug trials to same standards
- Author:
- HT Staff
Credit: FDA A new study suggests the US Food and Drug Administration (FDA) does not hold drug trials to the same set of standards. The research...
News
Brentuximab vedotin approved in Japan
- Author:
- HT Staff
Credit: Linda Bartlett The Japanese Ministry of Health, Labour and Welfare has approved brentuximab vedotin (Adcetris) for the treatment of...
News
FDA working to end IV fluid shortage
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has acknowledged the current shortage of intravenous (IV) solutions, particularly 0.9% sodium chloride...
News
ACA exchanges limiting for patients with blood cancers, report suggests
- Author:
- HT Staff
Credit: CDC A new report suggests that many health plans in the insurance exchanges mandated by the Affordable Care Act (ACA) will impose high...
News
CTLs prove effective against EBV lymphomas
- Author:
- HT Staff
Cytotoxic T lymphocytes (CTLs) targeting Epstein-Barr virus (EBV) proteins appear to be a promising treatment option for patients with aggressive...
News
Ponatinib back on the market
- Author:
- HT Staff
Ariad Pharmaceuticals, Inc., has begun shipping the drug to Biologics, Inc., its exclusive specialty pharmacy.
News
Committee votes against rivaroxaban for ACS
- Author:
- HT Staff
Credit: Mass.